IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2019

In Vitro Anticancer Activities of B6 Vitamers: A Mini-review. T. MATSUO, Y. SADZUKA (Iwate, Japan). Anticancer Res 39:3429-3432, 2019.
Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion. L. HELSON, M. MAJEED (East Windsor, NJ, USA). Anticancer Res 39:3423-3427, 2019.
Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology. A. RODALLEC, R. FANCIULLINO, S. BENZEKRY, J. CICCOLINI (Marseille; Bordeaux, France; Brussels, Belgium). Anticancer Res 39:3419-3422, 2019.
A Brief Guide to Performing Pharmacological Studies In Vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”. M. CAPULA, C. CORNO, B. EL HASSOUNI, G. LI PETRI, S. ARANĐELOVIĆ (Pisa; Milan; Palermo, Italy; Amsterdam, the Netherlands; Belgrade, Serbia). Anticancer Res 39:3413-3418, 2019.
State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now? R. BALSANO, C. TOMMASI, I. GARAJOVA (Parma, Italy). Anticancer Res 39:3405-3412, 2019.
Extracellular Vesicles: Subcellular Organelles With the Potential to Spread Cancer Resistance. F. ENDER, N. VON BUBNOFF, F. GIESELER (Luebeck, Germany). Anticancer Res 39:3395-3404, 2019.
Acyl-Coenzyme A: Cholesterol Acyltransferase Inhibition in Cancer Treatment. J. ZABIELSKA, T. SLEDZINSKI, E. STELMANSKA (Gdansk, Poland). Anticancer Res 39:3385-3394, 2019.
Inhibitors of Protein Tyrosine Phosphatase PTP1B With Anticancer Potential. T. KOSTRZEWA, J. STYSZKO, M. GORSKA-PONIKOWSKA, T. SLEDZINSKI, A. KUBAN-JANKOWSKA (Gdansk, Poland). Anticancer Res 39:3379-3384, 2019.
Glucans as New Anticancer Agents. P. SIMA, J. RICHTER, V. VETVICKA (Prague; Ústí nad Labem, Czech Republic; Louisville, KY, USA). Anticancer Res 39:3373-3378, 2019.
Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers – A Review. J.H. CHECK, D. CHECK (Camden; Mt. Laurel, NJ, USA). Anticancer Res 39:3365-3372, 2019.
Potential Molecular Mechanisms of the Anti-cancer Activity of Vitamin D. D. SKRAJNOWSKA, B. BOBROWSKA-KORCZAK (Warsaw, Poland). Anticancer Res 39:3353-3363, 2019.
Regulation of BS69 Expression in Cancers. Y. CHEN, Y.-H. TSAI, S.-H. TSENG (New Taipei; Taoyuan; Taipei, Taiwan, ROC). Anticancer Res 39:3347-3351, 2019.
From ‘Targeted Therapy’ to Targeted Therapy. G.J. PETERS (Amsterdam, the Netherlands). Anticancer Res 39:3341-3345, 2019.
Drug Delivery Systems for Phthalocyanines for Photodynamic Therapy. J. RAK, P. POUCKOVA, J. BENES, D. VETVICKA (Klecany; Prague, Czech Republic). Anticancer Res 39:3323-3339, 2019.
The Hippo Signaling Pathway in Pancreatic Cancer. D. ANSARI, H. OHLSSON, C. ALTHINI, M. BAUDEN, Q. ZHOU, D. HU, R. ANDERSSON (Lund, Sweden; Zhejiang; Wenzhou, PR China). Anticancer Res 39:3317-3321, 2019.
The Role of PEDF in Pancreatic Cancer. D. ANSARI, C. ALTHINI, H. OHLSSON, M. BAUDEN, R. ANDERSSON (Lund, Sweden). Anticancer Res 39:3311-3315, 2019.
To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology. B. EL HASSOUNI, G. MANTINI, G. LI PETRI, M. CAPULA, L. BOYD, H.N.W. WEINSTEIN, A. VALLÉS-MARTI, M.C.M. KOUWENHOVEN, E. GIOVANNETTI, B.A. WESTERMAN, G.J. PETERS (Amsterdam, the Netherlands; Pisa, Italy). Anticancer Res 39:3303-3309, 2019.
A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer. A. STRAVODIMOU, I.A. VOUTSADAKIS (Lausanne, Switzerland; Sault Ste. Marie; Sudbury, ON, Canada). Anticancer Res 39:3295-3301, 2019.
Clinical Significance of Selected Chemokines in Thyroid Cancer. A. MIRONSKA, M. ŁUKASZEWICZ-ZAJAC, B. MROCZKO (Bialystok, Poland). Anticancer Res 39:2715-2720, 2019.
Clinical Impact of Perioperative Oral/Dental Care on Cancer Surgery Outcomes. T. AOYAMA, A. TAMAGAWA (Yokohama, Japan). Anticancer Res 39:2711-2714, 2019.
Metastatic Carcinomas of the Adrenal Glands: From Diagnosis to Treatment. E. SPARTALIS, I. DRIKOS, A. IOANNIDIS, D. CHRYSIKOS, D.I. ATHANASIADIS, M. SPARTALIS, D. AVGERINOS (Athens; Thessaloniki, Greece; New York, NY, USA). Anticancer Res 39:2699-2710, 2019.
The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer. A. GZIL, Ł. SZYLBERG, D. JAWORSKI, J. DOMINIAK, I. ZARĘBSKA, D. GRZANKA (Bydgoszcz, Poland). Anticancer Res 39:2689-2697, 2019.
The Past, Present and Future of Immunotherapy for Metastatic Renal Cell Carcinoma. A.J. CHANG, L. ZHAO, Z. ZHU, K. BOULANGER, H. XIAO, M.R. WAKEFIELD, Q. BAI, Y. FANG (Des Moines, IA; Columbia, MO, USA; Hefei; Chenzhou, PR China). Anticancer Res 39:2683-2687, 2019.
11Boron Delivery Agents for Boron Proton-capture Enhanced Proton Therapy. K. HIDEGHÉTY, S. BRUNNER, A. CHEESMAN, E.R. SZABÓ, R. POLANEK, D. MARGARONE, T. TŐKÉS, K. MOGYORÓSI (Szeged, Hungary; Prague, Czech Republic). Anticancer Res 39:2265-2276, 2019.
Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors. S. KASHIWAGI, Y. ASANO, K. TAKAHASHI, M. SHIBUTANI, R. AMANO, S. TOMITA, K. HIRAKAWA, M. OHIRA (Osaka, Japan). Anticancer Res 39:2259-2264, 2019.
NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human Malignancies. T. KOKURYO, Y. YOKOYAMA, J. YAMAGUCHI, N. TSUNODA, T. EBATA, M. NAGINO (Nagoya, Japan). Anticancer Res 39:2251-2258, 2019.
Clinical Impact of Sarcopenia on Gastric Cancer. K. KUWADA, S. KURODA, S. KIKUCHI, R. YOSHIDA, M. NISHIZAKI, S. KAGAWA, T. FUJIWARA (Okayama, Japan). Anticancer Res 39:2241-2249, 2019.
Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography. A. GKANTAIFI, C. PAPADOPOULOS, D. SPYROPOULOU, M. TOUMPOURLEKA, G. ILIADIS, D. KARDAMAKIS, M. NIKOLAOU, N. TSOUKALAS, G. KYRGIAS, M. TOLIA (Thessaloniki; Patras; Athens; Larissa, Greece). Anticancer Res 39:1667-1673, 2019.
The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer. D. HU, D. ANSARI, M. BAUDEN, Q. ZHOU, R. ANDERSSON (Wenzhou, PR China; Lund, Sweden). Anticancer Res 39:1661-1666, 2019.
Recurrence Following Anastomotic Leakage After Surgery for Carcinoma of the Distal Esophagus and Gastroesophageal Junction: A Systematic Review. P. AURELLO, G. BERARDI, G. MOSCHETTA, M. CINQUEPALMI, L. ANTOLINO, G. NIGRI, F. D’ANGELO, S. VALABREGA, G. RAMACCIATO (Rome, Italy). Anticancer Res 39:1651-1660, 2019.
Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions. G. GOETZ, M. MITIC, T. MITTERMAYR, C. WILD (Vienna; Krems, Austria). Anticancer Res 39:1635-1650, 2019.
Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma. E. SPARTALIS, D.I. ATHANASIADIS, D. CHRYSIKOS, M. SPARTALIS, G. BOUTZIOS, D. SCHIZAS, N. GARMPIS, C. DAMASKOS, S.A. PASCHOU, A. IOANNIDIS, G. TSOUROUFLIS, D. DIMITROULIS, N.I. NIKITEAS (Athens; Thessaloniki, Greece). Anticancer Res 39:1119-1127, 2019.
Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling. I. VASYUTIN, L. ZERIHUN, C. IVAN, A. ATALA (Moscow, Russia; New York, NY; Winston-Salem, NC, USA). Anticancer Res 39:1105-1118, 2019.
GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review. K. SYRJÄNEN, M. ESKELINEN, A. PEETSALU, T. SILLAKIVI, P. SIPPONEN, M. HÄRKÖNEN, L. PALOHEIMO, M. MÄKI, T. TIUSANEN, O. SUOVANIEMI, F. DiMARIO, Z.P. FAN (Helsinki; Kuopio; Espoo, Finland; Barretos, Brazil; Tartu, Estonia; Parma, Italy; Shanghai, PR China). Anticancer Res 39:1091-1104, 2019.
Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer. N. AKSORN, P. CHANVORACHOTE (Bangkok, Thailand). Anticancer Res 39:541-548, 2019.
The Role of KRAS in Endometrial Cancer: A Mini-Review. M. SIDERIS, E.I. EMIN, Z. ABDULLAH, J. HANRAHAN, K.M. STEFATOU, V. SEVAS, E. EMIN, T. HOLLINGWORTH, F. ODEJINMI, S. PAPAGRIGORIADIS, S. VIMPLIS, F. WILLMOTT (London, UK; Patras; Ioannina; Athens, Greece). Anticancer Res 39:533-539, 2019.
MicroRNA-based Targeted Therapeutics in Pancreatic Cancer. N. GURBUZ, B. OZPOLAT (Isparta, Turkey; Houston, TX, USA). Anticancer Res 39:529-532, 2019.
Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges. M. SEDIĆ, P. GRBČIĆ, S. KRALJEVIĆ PAVELIĆ (Rijeka, Croatia). Anticancer Res 39:41-56, 2019.
MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma. A. ZEMBSKA, A. JAWIARCZYK-PRZYBYŁOWSKA, B. WOJTCZAK, M. BOLANOWSKI (Wroclaw, Poland). Anticancer Res 39:33-40, 2019.
Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery. D. HASHIMOTO, T. OKAWA, R. MARUYAMA, F. MATSUMURA, Y. SHIBATA, H. KOHROGI (Kumamoto; Omuta, Japan). Anticancer Res 39:25-31, 2019.
An Update on the Current Role of High Resolution Anoscopy in Patients With Anal Dysplasia. A. GUDUR, D. SHANMUGANANDAMURTHY, Z. SZEP, J.L. POGGIO (Philadelphia, PA, USA). Anticancer Res 39:17-23, 2019.
Evolution of Cancer Progression in the Context of Darwinism. L. LACINA, M. ČOMA, B. DVOŘÁNKOVÁ, O. KODET, N. MELEGOVÁ, P. GÁL, K. SMETANA JR (Prague; Vestec, Czech Republic; Košice; Bratislava, Slovak Republic). Anticancer Res 39:1-16, 2019.
Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review. R. GERA, S. TAYEH, H. EL-HAGE CHEHADE, K. MOKBEL (London, UK). Anticancer Res 38:6615-6620, 2018.
Application of Artificial Intelligence-based Technology in Cancer Management: A Commentary on the Deployment of Artificial Neural Networks. G.V. SHERBET, W.L. WOO, S. DLAY (Huntington Beach, CA, USA; Newcastle upon Tyne, UK). Anticancer Res 38:6607-6613, 2018.
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead. M. ASLAN, R. SHAHBAZI, K. ULUBAYRAM, B. OZPOLAT (Ankara, Turkey; Houston, TX, USA). Anticancer Res 38:6591-6606, 2018.
Collision Tumors of the Gastrointestinal Tract: A Systematic Review of the Literature. D. SCHIZAS, I. KATSAROS, A. MICHALINOS, C. DAMASKOS, N. GARMPIS, V. NTOMI, G. AGROGIANNIS, S. STERGIOPOULOS, A.K. TSAROUCHA (Athens; Alexandroupolis, Greece). Anticancer Res 38:6047-6057, 2018.
Technical Advances in Radiation Therapy for Brain Tumors. C. SCARINGI, L. AGOLLI, G. MINNITI (Rome; Pozzilli, Italy; Dresden, Germany). Anticancer Res 38:6041-6045, 2018.
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC. S. GIACINTI, G. POTI, M. ROBERTO, S. MACRINI, M. BASSANELLI, F. DI PIETRO, A.M. ASCHELTER, A. CERIBELLI, E.M. RUGGERI, P. MARCHETTI (Viterbo; Rome; Rieti, Italy). Anticancer Res 38:6029-6039, 2018.
Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne? S. BOUSSIOS, C. HAYWARD, D. COOKE, N. ZAKYNTHINAKIS-KYRIAKOU, A.K. TSIOURIS, A.A. CHATZIANTONIOU, F.S. KANELLOS, A. KARATHANASI (Kent; Leicester, UK; Ioannina, Greece). Anticancer Res 38:5589-5597, 2018.
Surgical Endoscopic Vacuum-assisted Closure Therapy (EVAC) in Treating Anastomotic Leakages After Major Resective Surgery of Esophageal and Gastric Cancer. E. VIRGILIO, D. CECI, M. CAVALLINI (Rome, Italy). Anticancer Res 38:5581-5587, 2018.
Page: 1 2 3 4 5 6 ... 8 9 10 11 12 13 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system